METOPIRONE 250mg soft capsules ESTEVEPHSA
Chemical substance: metirapone
ATC code: V04CD01 • Various | Other diagnostic agents | Tests for pituitary function
Active substance
Results for the substance metirapone
1 result
About this active substance
Metyrapone is a cortisol synthesis inhibitor used for the diagnosis of adrenal insufficiency and the treatment of Cushing's syndrome. It works by inhibiting the enzyme 11-beta-hydroxylase, reducing cortisol production.
The medication is taken orally, usually in divided doses, with the dose adjusted based on the patient's response and hormone levels. Common side effects include nausea, vomiting, abdominal pain, and dizziness.
Metyrapone is contraindicated in patients with hypersensitivity to the active substance or severe hepatic impairment. Its use also requires careful monitoring of adrenal function and blood pressure.
This medication is an important option for diagnosing and managing adrenal disorders, helping to improve patients' quality of life.
The medication is taken orally, usually in divided doses, with the dose adjusted based on the patient's response and hormone levels. Common side effects include nausea, vomiting, abdominal pain, and dizziness.
Metyrapone is contraindicated in patients with hypersensitivity to the active substance or severe hepatic impairment. Its use also requires careful monitoring of adrenal function and blood pressure.
This medication is an important option for diagnosing and managing adrenal disorders, helping to improve patients' quality of life.